指南与共识慢性肾脏病血液净化与透析肾移植

营养性维生素D在慢性肾脏病-矿物质骨异常中的作用:欧洲共识声明

The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement.
指南 / 共识 · Nephrol Dial Transplant · 2025-01-01

该欧洲共识由ERA与ESPN专家小组基于广泛文献综述制定,经Delphi小组审议,针对儿童和成人CKD、透析及肾移植患者,建议监测并纠正维生素D缺乏,目标25-羟基维生素D>75 nmol/l(>30 ng/ml),避免超大剂量(≥100 000 IU)和过高水平(>150-200 nmol/l),未来需进一步研究患者相关结局。

要点

  • 建议监测并纠正CKD及肾移植后儿童和成人的维生素D缺乏。
  • 目标25-羟基维生素D水平>75 nmol/l(>30 ng/ml)。
  • 避免超大剂量(≥100 000 IU)及25-羟基维生素D>150-200 nmol/l。

核心结论

  • 建议对CKD及肾移植后儿童和成人监测并纠正维生素D缺乏,目标25-羟基维生素D>75 nmol/l(>30 ng/ml)。
  • 维生素D补充耐受性和安全性良好,但应避免超大剂量(≥100 000 IU)和过高25-羟基维生素D水平(>150-200 nmol/l)。

研究设计与样本

  • 欧洲肾脏骨营养不良倡议(ERA)与欧洲儿科肾脏病学会(ESPN)合作,专家小组进行广泛文献综述并制定临床实践要点。
  • 实践要点由ERA和ESPN相关工作组组成的Delphi小组审议。

主要发现

  • 维生素D缺乏在CKD患者中常见并与不良结局相关。
  • 普通人群近期大规模临床试验未显示维生素D补充对骨骼或非骨骼结局的获益。
  • 维生素D补充耐受性和安全性良好,但需避免超大剂量和过高25-羟基维生素D水平以降低毒性风险。

关键数值与推荐

  • 目标25-羟基维生素D水平>75 nmol/l(>30 ng/ml)。
  • 避免超大剂量维生素D补充(≥100 000 IU)。
  • 避免25-羟基维生素D水平>150-200 nmol/l(60-80 ng/ml)。

临床怎么用

  • 在CKD及肾移植后儿童和成人中监测维生素D缺乏并纠正至目标25-羟基维生素D>75 nmol/l(>30 ng/ml)。
  • 补充维生素D时避免单次超大剂量(≥100 000 IU),并监测25-羟基维生素D不超过150-200 nmol/l。

局限性

  • 未来临床试验需在不同CKD分期维生素D缺乏人群中研究维生素D补充对患者相关结局的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitamin D deficiency is common in patients with chronic kidney disease (CKD) and associates with poor outcomes. Current clinical practice guidelines recommend supplementation with nutritional vitamin D as for the general population. However, recent large-scale clinical trials in the general population failed to demonstrate a benefit of vitamin D supplementation on skeletal or non-skeletal outcomes, fueling a debate on the rationale for screening for and correcting vitamin D deficiency, both in non-CKD and CKD populations. In a collaboration between the European Renal Osteodystrophy initiative of the European Renal Association (ERA) and the European Society for Paediatric Nephrology (ESPN), an expert panel performed an extensive literature review and formulated clinical practice points on vitamin D supplementation in children and adults with CKD and after kidney transplantation. These were reviewed by a Delphi panel of members from relevant working groups of the ERA and ESPN. Key clinical practice points include recommendations to monitor for, and correct, vitamin D deficiency in children and adults with CKD and after kidney transplantation, targeting 25-hydroxyvitamin D levels >75 nmol/l (>30 ng/ml). Although vitamin D supplementation appears well-tolerated and safe, it is recommended to avoid mega-doses (≥100 000 IU) and very high levels of 25 hydroxyvitamin D (>150-200 nmol/l, or 60-80 ng/ml) to reduce the risk of toxicity. Future clinical trials should investigate the benefit of vitamin D supplementation on patient-relevant outcomes in the setting of vitamin D deficiency across different stages of CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Jørgensen HS, Vervloet M, Cavalier E, et al. The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement. Nephrol Dial Transplant. 2025. PMID: 39875204. doi:10.1093/ndt/gfae293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。